OncBioMune Receives Notice of Patent Allowance for Cancer Vaccine ProscaVax(TM) in Europe Life Science Investing
Inovio Pharmaceuticals Signs Collaborative Research Agreements With Wistar Institute Life Science Investing
DelMar Pharmaceuticals Announce FDA Grants Second Orphan Designation For VAL-083 Life Science Investing
FibroGen Announces Publication of Phase 2 Study Results Supporting the Potential of FG-3019 Biotech Investing
Actinium Pharmaceuticals Initiates Pursuit of EU Orphan Designation for Iomab-B Life Science Investing
